Limba
|
R1530 is a highly potent, orally bioavailable, dual-acting mitosis/angiogenesisinhibitor for the treatment of solid tumors, which can inhibit vascular endothelial growth factor receptor 2 (VEGFR2)and fibroblast growth factor receptors 1 (FGFR1)with IC50s of 10 nM and 28 nM, respectively.
Price | 1.597,00 RON (preturile sunt fara TVA) |
---|---|
Description |
R1530 is a highly potent, orally bioavailable, dual-acting mitosis/angiogenesisinhibitor for the treatment of solid tumors, which can inhibit vascular endothelial growth factor receptor 2 (VEGFR2)and fibroblast growth factor receptors 1 (FGFR1)with IC50s of 10 nM and 28 nM, respectively. |